-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UT/x3gUeDYwHeToDPXMBBnVGVSZKVjmOavfRlIkc+iM5cb7B+t8qbG8bBE7UutMs ruajx5Kq6c5MpFAqLigNjw== 0001451522-09-000011.txt : 20090727 0001451522-09-000011.hdr.sgml : 20090727 20090727162138 ACCESSION NUMBER: 0001451522-09-000011 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090727 DATE AS OF CHANGE: 20090727 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Kruse Alan Dale CENTRAL INDEX KEY: 0001451522 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 2082 SALTO DRIVE CITY: HACIENDA HEIGHTS STATE: CA ZIP: 91745 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MIRACOR DIAGNOSTICS INC CENTRAL INDEX KEY: 0000723906 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 581475517 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-35708 FILM NUMBER: 09964792 BUSINESS ADDRESS: STREET 1: 9191 TOWNE CENTRE DR STREET 2: STE 400 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 8584557127 MAIL ADDRESS: STREET 1: 9191 TOWNE CENTRE DRIVE STREET 2: STE 400 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL DEVICE TECHNOLOGIES INC DATE OF NAME CHANGE: 19950518 FORMER COMPANY: FORMER CONFORMED NAME: CYTOPROBE CORP DATE OF NAME CHANGE: 19930929 SC 13D/A 1 mirajul27.txt 13D/A AMENDMENT 4 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 04) (Name of Issuer) MIRACOR DIAGNOSTICS, INC. ................................................................................ (Title of Class of Securities) Common Stock, $0.15 par value per share ................................................................................ (CUSIP Number) 60461S104 ................................................................................ (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) Alan D. Kruse 2082 Salto Dr. Hacienda Heights, CA 91745 (702) 285-4262 ................................................................................ (Date of Event Which Requires Filing of This Statement) July 24, 2009 ................................................................................ If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box.[ ] CUSIP No. 60461S104 Schedule 13D Page 2 of 4 Pages Amendment 4 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Alan D. Kruse.......................................... 2. Check the Appropriate Box if a Member of a Group: (a) Not applicable....................................... (b) Not applicable....................................... 3. SEC Use Only ................................................ 4. Source of Funds ...[PF].............................. 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e): .....Not applicable............. 6. Citizenship or Place of Organization ..USA................... Number of 7. Sole Voting Power...3,767,969........................ Shares Bene- ficially owned 8. Shared Voting Power....0.......................... by Reporting 9. Sole Dispositive Power ......3,767,969............... Person With 10. Shared Dispositive Power .......0................ 11. Aggregate Amount Beneficially Owned by Each Reporting Person ...3,767,969............. 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares ......[ ]................ 13. Percent of Class Represented by Amount in Row (11) 21.27% ...... 14. Type of Reporting Person...[IN]................ CUSIP No. 60461S104 Schedule 13D Page 3 of 4 Pages Amendment 4 Item 4 is amended as follows: 4 (v) The Reporting person may from time to time, conduct open market operations to ensure liquidity in the market and/or to detect the intentions of prospective purchasers and sellers. Item 5(c) is amended as follows to reflect recent transactions. (c) The following transactions were made by the Reporting Person in the open market during the sixty days prior to this current amended filing. 166,255 net shares purchased aggregate purchase price of $722.82 (.0043/sh) 341,497 net shares purchased aggregate purchase price of $1274.81 (.0037/sh) CUSIP No. 60461S104 Schedule 13D Page 4 of 4 Pages Amendment 4 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: July 27, 2009 /s/ Alan D. Kruse Name: Alan D. Kruse -----END PRIVACY-ENHANCED MESSAGE-----